Journals / Genel Tıp Dergisi / 1999 / Cilt: 9 - Sayı: 4

Experimental tuberculosis peritonitis model in immunosupprese BALB / c mice

İmmunosuprese BALB / c farelerde deneysel tüberküloz peritonit modeli

Pages
131–134
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Histopathological investigations revealed of fatty peritoneal tissues and granulomas consisted of epiteloid histiocytes in mice given immunosuppressive drug whereas such changes were not observed in normal mice.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The risk of infected by tuberculosis is increased at patients with lenfoma, silicosis or cancer and undergoing postgastrectomy and taking immunosuppressive and steroid therapy.
📊
Key Findings & Data:Methods: In this study, 12 BALB/c mice injected immune suppressive drugs and 12 normal BALB/c mice were used.
💡
Conclusion & Impact:Conclusion: Histopathological investigations revealed of fatty peritoneal tissues and granulomas consisted of epiteloid histiocytes in mice given immunosuppressive drug whereas such changes were not observed in normal mice.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Hastalık modelleri · hayvan · İmmün baskılama

Abstract

Objective: The risk of infected by tuberculosis is increased at patients with lenfoma, silicosis or cancer and undergoing postgastrectomy and taking immunosuppressive and steroid therapy. Methods: In this study, 12 BALB/c mice injected immune suppressive drugs and 12 normal BALB/c mice were used. We compared these two groups mice for suffering peritonitis and histopathological changes of visceral organs. 0.1 ml Mycobacterium tuberculosis strain concentrated in 105 CFU/ml was injected intraperitoneally all of the mice. Results: More acides, palening of visceral organs, hepatosplenomegali and widening of small intestinal loop were observed in mice given immunosuppressive drugs. Otherwise less ascites, palening of visceral organs, minimal widens of small intestines loop were observed in normal mice. Conclusion: Histopathological investigations revealed of fatty peritoneal tissues and granulomas consisted of epiteloid histiocytes in mice given immunosuppressive drug whereas such changes were not observed in normal mice.

Özet

Amaç: Kontrolsüz diabet, lenfoma, postgastrektomi, silikozis gibi durumlarda, immunosupresif ve steroid tedavilerinde ve kanserli hastalard tüberküloz oluşma riski artmaktadır. Bu çalışmada immunosupresyon uygulanan ve uygulanmayan farelerde tüberküloz peritonit oluşum sürelerini ve histopatolojik olarak organ tutulumlarını karşılaştırmayı amaçladık. Yöntem: Çalışmamızda 12 immunosupresyon yapılan ve 12 sağlıklı, toplam 24 BALB/c fare kullanılmıştır. İmmunosupresyon yapılan ve yapılmayan sağlıklı fareler 10x5 CFU/ml Mycobacterium tuberculosis içeren solusyondan 0.1 ml intraperitoneal yolla enfekte edilmiştir. Bulgular: İmmunosupresif grupta ileri derece asit, tüm organlarda solukluk, hepatosplenomegali ve ince barsak anslarında ileri derecede genişleme tespit edilmiştir. İmmunsupresyon yapılmayan grupta az miktarda asit, organlarda solukluk ve barsak anslarında minimal düzeyde genişleme gözlenmiştir. Sonuç: İmmunosupresif grupta alınan örneklerin histopatolojik incelemesinde peritoneal yağlı doku ve akciğerlerde epiteloid histiositler tarafından oluşturulmuş granülom yapıları görülmesi, ancak sağlıklı grupta granülom yapılarına rastlanmaması iki grup arasındaki anlamlı farkı ifade etmektedir.

🔖

Cite This Article

ASLAN, G., ULUKANLIGİL, M., ÖZARDALI, İ. (1999). Experimental tuberculosis peritonitis model in immunosupprese BALB / c mice. Genel Tıp Dergisi, Cilt: 9 - Sayı: 4, 131–134. https://ajindex.com/articles/225132

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Han JK, Kim SH, Choi BI, Yeon KM, Han MC. Tuberculous colitis. Dis Colon Rectum 1996;39:1204-9.
  2. Braun MM, Cote TR, Rabkin CS. Trends in death with tuberculosis during in AIDS era. JAMA 1993;269:2865-8.
  3. Rieder HL, Snider DE, Cauthen GM. Extrapulmonary tuberculosis in the United States. Am Rev Respir Dis 1990;141:374-81.
  4. Haas DW, Des Prez RM. Mycobacterium tuberculosis. In: Mandell GL, Douglas RG, Bennett JE, editors. Principles and practice of infectious diseases. 4th ed. New York: Churcill-Livingstone; 1995. p.2213-43.
  5. Epstein BM, Mann JH. CT of Abdominal tuberculosis. AJR 1982;139:861. Ağıldere AM, Coşkun M, Demirhan B, Karakayalı H, Niron EA, Haberal M. Renal transplantasyon olgusunda gelişen ileoçekal tüberkülozun bilgisayarlı tomografi (BT) bulguları. Diyaliz Transplantasyon Yanık 1996;9:43-7.
  6. Moray G, Karakayalı H, Şenel MF, Köseoğlu F, Bilgin N, Haberal M. 744 renal transplant alıcısında tüberküloz insidansı ve bir intestinal tüberküloz vakasının takdimi. Diyaliz Transplantasyon Yanık 1996;9:53-6.
  7. Phyu S, Musrafa T, Hofstad T, Nilsen R, Fosse R, Bjune G. A mouse for latent tuberculosis. Scand J Infect Dis 1998;30:59-68.
  8. Cooper AM, Calahan JE, Keen M, Behsle JT, Orme IM. Expression of memory immunity in the lung following re-exposure to Mycobacterium tuberculosis. Tuber Lung Dis 1997;78:67-73.
  9. Ji B, Lounis N, Maslo C, Truffot-Pernot C, Bonnafous P, Grosset J. In vitro and invivo activities of moxifloxacin and clinafloxacin aganist Mycobacterium tuberculosis. Antimicrob Agents Chemother 1998; 42:2066-9.
  10. LoBue PA, Catanzaro A. The diagnosis of tuberculosis. Dis Mon 1997;43:185-246.